Experiencing a miscarriage can be emotionally difficult, especially for intended parents who have already spent months or years trying to build their family. After a miscarriage, some people begin exploring surrogacy as another path to parenthood. However, the decision should involve more than choosing a program or clinic. It is also worth understanding the medical reasons behind the miscarriage, reviewing fertility factors, and making sure the next pregnancy has appropriate medical support.

Surrogacy after miscarriage does not necessarily mean that another pregnancy will have the same outcome. Miscarriages are relatively common, and many occur because of chromosomal abnormalities that happen by chance. Still, when a miscarriage has occurred, particularly when there have been multiple losses, doctors may recommend additional evaluation before another pregnancy or embryo transfer.

For intended parents considering surrogacy in Colombia, a detailed medical review can help clarify what should be addressed before moving forward.

Can Intended Parents Consider Surrogacy After a Miscarriage?

Yes. A previous miscarriage does not automatically prevent intended parents from pursuing gestational surrogacy.

In gestational surrogacy, the surrogate carries an embryo created through IVF. The surrogate typically has no genetic relationship with the baby. The embryo may be created using the intended mother’s egg and intended father’s sperm, or donor eggs and/or sperm, depending on the circumstances.

This distinction can be medically useful after miscarriage because the fertility team can separately evaluate:

• The intended mother’s egg and reproductive health.
• The intended father’s sperm quality.
• The embryo.
• The surrogate’s ability to carry a pregnancy.
• The IVF laboratory and embryo-transfer process.

The right approach depends heavily on why the miscarriage occurred and whether the intended parents are using their own eggs and sperm.

Why Did the Miscarriage Happen?

One of the first medical questions after a miscarriage is whether the cause can be identified.

Sometimes there is no clear explanation. ACOG states that early pregnancy loss is common and that chromosomal abnormalities are a frequent cause of early miscarriage.

Possible factors can include:

• Chromosomal abnormalities in the embryo.
• Problems involving the uterus.
• Hormonal or endocrine conditions.
• Certain infections.
• Blood-clotting or immune-related conditions in selected cases.
• Maternal health conditions.
• Age-related changes in egg quality.
• Sperm-related factors.
• Other medical or genetic factors.

Importantly, a miscarriage is not automatically caused by something the woman did. Normal activities such as working, exercising, having sex, or experiencing everyday stress are generally not considered causes of most early miscarriages.

One Miscarriage vs. Recurrent Pregnancy Loss

The medical evaluation can be different depending on the pregnancy history.

After a single early miscarriage, doctors may not recommend an extensive investigation because many isolated miscarriages happen due to random chromosomal abnormalities.

However, recurrent pregnancy loss may require a more detailed assessment. ACOG defines recurrent pregnancy loss as having two or more miscarriages and recommends a medical evaluation after two miscarriages.

The evaluation may include a review of:

• Previous pregnancy records.
• Ultrasound findings.
• Medical conditions.
• Menstrual and reproductive history.
• Family history.
• Genetic factors.
• Uterine anatomy.
• Relevant laboratory tests.

The exact testing should be decided by a fertility specialist rather than ordering every possible test automatically.

Reviewing the Embryo After a Miscarriage

When IVF has been used, embryo-related factors may receive particular attention.

Chromosomal abnormalities are one of the most common explanations for early pregnancy loss. An embryo can have an abnormal number or structure of chromosomes even when both intended parents are healthy.

If pregnancy tissue was tested after a miscarriage, the results can sometimes provide useful information about the pregnancy loss. Depending on the circumstances, doctors may discuss genetic testing of products of conception or other genetic investigations.

For future IVF cycles, some intended parents may also ask about preimplantation genetic testing for aneuploidy (PGT-A).

PGT-A evaluates embryos for chromosome number abnormalities before transfer. However, it is not a guarantee of a successful pregnancy or live birth, and it is not appropriate or beneficial for every patient. ASRM states that the value of PGT-A varies according to patient circumstances and that its routine use for all IVF patients has not been established.

Therefore, intended parents should discuss the potential benefits, limitations, costs, and alternatives with their fertility specialist.

Checking the Intended Mother’s Health

If the intended mother will no longer carry the pregnancy but will provide the egg, her overall reproductive health can still matter.

Egg quality is influenced by age and other biological factors. The fertility specialist may review ovarian reserve and previous IVF results.

Possible assessments can include:

• Antral follicle count through ultrasound.
• Anti-Müllerian hormone (AMH).
• Follicle-stimulating hormone (FSH), when appropriate.
• Estradiol testing in selected situations.
• Review of previous stimulation and IVF cycles.

These tests do not directly predict whether an individual embryo will result in a live birth. They mainly help the fertility team understand ovarian response and plan treatment.

If donor eggs are being considered, the medical assessment will be different because the genetic material comes from the egg donor.

Evaluating Sperm Health

The sperm contributor’s health should not be overlooked.

Sperm quality can influence fertilization and embryo development. A basic semen analysis can assess factors such as sperm concentration, movement, and morphology.

If previous IVF cycles produced poor fertilization, low-quality embryos, or repeated pregnancy losses, a fertility specialist may consider whether additional male-factor evaluation is appropriate.

Not every intended father needs extensive testing after a single miscarriage. The decision should be based on the complete reproductive history.

Is the Surrogate’s Health Important?

Yes.

Even though the surrogate is not genetically related to the baby in gestational surrogacy, her health directly affects the pregnancy.

Before embryo transfer, the surrogate generally undergoes medical screening to determine whether she is suitable for pregnancy.

This may include:

• Medical and pregnancy history.
• Physical examination.
• Blood tests.
• Infectious-disease screening.
• Blood group and Rh testing.
• Cervical screening when appropriate.
• Uterine evaluation.
• Review of medications.
• Assessment of vaccination and immunity status.

The fertility clinic may also evaluate the surrogate’s previous pregnancies and deliveries.

A healthy pregnancy requires more than an embryo with suitable characteristics. The uterus, hormonal environment, general health, and prenatal care all matter.

Uterine Evaluation Before Embryo Transfer

For intended parents who experienced a miscarriage, uterine evaluation may become particularly relevant if there is a history suggesting a structural problem.

Conditions such as fibroids, polyps, uterine adhesions, or congenital uterine abnormalities can sometimes affect implantation or pregnancy.

When the surrogate is preparing for embryo transfer, the fertility clinic may use ultrasound or another method to evaluate the uterine cavity.

For intended parents researching surrogacy in Cyprus, it is useful to ask the clinic what type of uterine screening is performed before a surrogate is medically cleared.

The exact protocol can differ between fertility centers.

Should Hormones Be Checked?

Hormonal testing depends on the individual’s medical history.

Certain endocrine conditions can affect fertility and pregnancy. Thyroid disorders and poorly controlled diabetes, for example, may require management before pregnancy.

However, ordering a large panel of hormones after every miscarriage is not necessarily useful.

Doctors generally select tests based on the person’s symptoms, previous pregnancy history, age, fertility history, and other medical factors.

The goal should be to identify conditions that can actually change medical management.

What About Blood-Clotting Tests?

Blood-clotting disorders are sometimes discussed after miscarriage, but testing should be targeted.

One condition that doctors may investigate in people with recurrent pregnancy loss is antiphospholipid syndrome (APS), an autoimmune condition associated with pregnancy complications.

On the other hand, broad testing for every inherited thrombophilia is not recommended routinely for all people after a miscarriage. The appropriate evaluation depends on personal and family history and the pattern of pregnancy losses.

This is a good example of why medical evaluation should be individualized rather than based on an online checklist.

Genetic Counseling May Be Helpful

Genetic counseling can be useful when there have been repeated miscarriages, a known genetic condition, abnormal pregnancy testing, or other reasons to suspect a genetic factor.

A genetic counselor can review:

• The intended parents’ family histories.
• Previous pregnancy outcomes.
• Results from genetic testing.
• Possible inherited conditions.
• Available reproductive options.

In some cases, parental chromosome testing may be discussed, particularly after recurrent pregnancy loss.

Genetic counseling can help intended parents understand what a test can actually tell them before deciding to proceed.

Choosing a Surrogacy Program After Miscarriage

Medical care should remain a major consideration when comparing international surrogacy programs.

For example, people exploring surrogacy in Colombia may want to ask fertility providers about their screening procedures, IVF laboratory standards, embryo-transfer protocols, prenatal monitoring, and emergency medical arrangements.

Similarly, anyone researching surrogacy in Cyprus should understand who manages the medical care before, during, and after embryo transfer.

The same principle applies when working with a surrogacy agency in Mexico. An agency may coordinate services, but intended parents should understand which fertility clinic and doctors are actually responsible for medical decisions.

An agency’s role and a fertility clinic’s medical role are not necessarily the same.

Questions Intended Parents Should Ask the Clinic

Before beginning treatment, intended parents can ask the fertility team:

What could have caused our previous miscarriage?

The answer will depend on the available medical records and whether the pregnancy was genetically tested.

Do we need additional testing before another embryo transfer?

Not everyone needs extensive testing, but recurrent losses may justify a more detailed evaluation.

Does the surrogate undergo a complete medical screening?

Ask for the actual screening protocol rather than relying on a general statement that the surrogate is “medically cleared.”

Will our previous miscarriage change the IVF protocol?

The answer may depend on embryo quality, maternal age, ovarian response, sperm factors, and previous IVF results.

Should we consider PGT-A?

This should be discussed with a reproductive specialist because PGT-A has potential benefits and limitations.

Who provides prenatal and emergency care for the surrogate?

This is particularly important in international arrangements.

Preparing for Another Pregnancy

After a miscarriage, it can be tempting to move immediately toward another attempt. But taking time to review the medical history can make the next step more informed.

The fertility team may recommend:

• Reviewing previous pregnancy and IVF records.
• Completing targeted medical testing.
• Addressing untreated medical conditions.
• Reviewing medications and supplements.
• Optimizing general health.
• Evaluating embryos when appropriate.
• Selecting a medically suitable surrogate.
• Creating a clear prenatal-care plan.

Folic acid supplementation is also commonly recommended before pregnancy, although the appropriate dose can depend on individual circumstances. Intended parents should follow the advice of their healthcare provider.

Emotional Recovery Matters Too

Medical preparation is only one part of recovering from a miscarriage.

Some intended parents may experience sadness, anxiety, guilt, frustration, or fear about another pregnancy. These reactions can continue even after the physical recovery is complete.

Counseling or psychological support can be useful, particularly when miscarriage has occurred repeatedly or the fertility journey has been prolonged.

Surrogacy can also involve its own emotional and practical decisions, so intended parents should have enough time to understand the process before committing.

What Happens After Embryo Transfer?

Once the surrogate is medically prepared, the fertility team schedules embryo transfer according to the treatment plan.

If implantation occurs, a pregnancy test is usually performed after the appropriate interval. Early pregnancy may then be monitored with blood tests and ultrasound.

The pregnancy continues under the care of an obstetric team, with routine prenatal screening and additional monitoring when medically indicated.

A previous miscarriage does not mean that the next pregnancy will have the same outcome. At the same time, no fertility treatment can guarantee a successful pregnancy.

Final Thoughts

Surrogacy after miscarriage can be a reasonable option for intended parents, but the medical plan should begin with understanding the previous pregnancy loss. A single miscarriage may not require extensive investigation, while recurrent losses can justify a more detailed evaluation.

The most useful approach is usually targeted medical assessment rather than testing everything possible. Reviewing embryo factors, reproductive health, sperm quality, uterine conditions, genetic factors, and relevant medical conditions can help doctors decide what should happen next.

For families considering surrogacy in Colombia, researching the medical standards of the fertility clinic is just as important as understanding the overall surrogacy process. Those exploring surrogacy in Cyprus should similarly ask about surrogate screening, IVF protocols, embryo transfer, and prenatal care. If working with a surrogacy agency in Mexico, intended parents should also clarify which medical providers are responsible for fertility treatment and pregnancy care.

Most importantly, intended parents should discuss their individual history with a qualified fertility specialist. A previous miscarriage is one part of the medical story, not necessarily a prediction of what will happen in the future.